Tag: GDUFA III
Generic Drug User Fee Amendments: How GDUFA Laws Speed Up FDA Review
GDUFA laws let the FDA collect fees from generic drug makers to speed up approval of affordable medications. Since 2012, review times have dropped from years to months, helping millions access low-cost drugs faster.
view morerecent posts
Generic drugs cost far less than brand-name drugs not because ingredients are cheaper, but because labor costs are structured differently. Learn how scale, regulation, and global production shape the real cost of your prescriptions.
Published ON: 9 FebLearn how post-marketing studies track drug safety after approval, using FAERS, Sentinel, and real-world data to catch hidden risks. Understand the systems, challenges, and future of pharmacovigilance.
Published ON: 11 FebTeam-based care transforms how generic drugs are prescribed by bringing together doctors, pharmacists, and nurses to improve safety, adherence, and cost savings - especially for patients with multiple chronic conditions.
Published ON: 18 FebLearn how to verify online pharmacy licenses to avoid counterfeit drugs. Step-by-step guide to using state and NABP verification systems for safe medication purchases.
Published ON: 15 FebDiscover how the FDA maintains strict quality standards for generic drugs through cGMP regulations, unannounced inspections, and rigorous testing. Learn about the five key control areas, global comparisons, and real-world impact on drug safety and affordability.
Published ON: 4 Feb